HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AKESO

93.600

-1.450-1.53%

Volume:7.15M

Turnover:672.65M

Market Cap:86.21B

PE:-64.94

High:96.000

Open:95.050

Low:93.400

Close:95.050

52wk High:156.000

52wk Low:80.200

Shares:921.00M

HK Float Shares:921.00M

Volume Ratio:0.46

T/O Rate:0.78%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.441

ROE:-13.59%

ROA:-4.57%

PB:8.69

PE(LYR):-64.94

PS:21.37

Loading ...

Overview Company News Filings

Akeso Interim 2026 Results: Revenue Reaches RMB 1.81 Billion, Net Loss Narrows by 24.0%

Bulletin Express

Akeso FY26 H1 Net Loss Narrows 23.98% to RMB 447.2 Million; Revenue Rises 27.92% to RMB 1.81 Billion

Akeso Surges Over 6% Intraday as Guosen Securities Initiates 'Outperform' Rating

Movement Alert｜AKESO Rises 3.03% in Regular Trading, Ivonescimab Biliary Tract Cancer Phase 3 Meets Primary OS Endpoint Amid Interim Results Release

Morning Market Wrap: Hong Kong Shares Rise 0.68% as Copper Stocks Take the Lead

China's Akeso Jumps on Progress of Immunotherapy Drug for Cancer Treatment

AKESO Surges Over 9% in Session as Evonex Achieves Positive Phase III Results in Biliary Tract Cancer

Akeso's Ivonescimab Meets Primary Endpoint in Phase 3 Biliary Tract Cancer Trial

MT Newswires Live

Movement Alert｜AKESO Rises 6.64% in Regular Trading, Phase III Trial for Ivonescimab in Biliary Tract Cancer Achieves Significant OS Benefit

Akeso Says Ivonescimab Plus Chemo Meets Primary Endpoint

HK Stock Market Highlights: Haizhi Tech's H1 FY2026 Revenue Jumps 70.4% as Agent Business Takes Off

AKESO's Novel Dual Antibody Achieves Positive Phase III Results in Biliary Tract Cancer, Marking First Solid Tumor Expansion Beyond Lung Cancer

Akeso: Ivonescimab Plus Chemotherapy Delivers Statistically Significant OS Improvement in Phase III Biliary Tract Cancer Trial

Bulletin Express

Akeso - Ivonescimab Plus Chemo Meets Primary Endpoint with Significant Os Benefit in 1L BTC

THOMSON REUTERS

Akeso - Harmoni-Gi1 First Phase Iii Study to Show Significant Os Benefit Versus Global Standard in Biliary Tract Cancer

THOMSON REUTERS

Ivonescimab Plus Chemotherapy Demonstrates Significant Overall Survival Benefit Versus Durvalumab Plus Chemotherapy in First-Line Biliary Tract Cancer: Harmoni-Gi1 Meets Primary Endpoint

THOMSON REUTERS

Akeso - Study Meets Key Secondary Endpoints of Progression-Free Survival and Objective Response Rate

THOMSON REUTERS

Movement Alert｜AKESO Rises 3.49% in Regular Trading, Interim Results Imminent and New ADC Pipeline Progress Boosts Sentiment

Akeso Says China NMPA Clears Phase I Trial for B7-H3 ADC Ak157d1 in Solid Tumors

Akeso's Ak157d1 (B7-H3 ADC) Cleared for Phase I Trial in Solid Tumors, Adding a Third Differentiated ADC to Its Pipeline

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/09926/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"09926","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09926\",,,,,undefined,":{"symbol":"09926","market":"HK","secType":"STK","nameCN":"AKESO","latestPrice":93.6,"timestamp":1789027724006,"preClose":95.05,"halted":0,"volume":7151000,"delay":0,"changeRate":-0.015255128879537116,"floatShares":921000000,"shares":921000000,"eps":-1.4413165975581068,"marketStatus":"Closed","change":-1.45,"latestTime":"09-10 16:08:44","open":95.05,"high":96,"low":93.4,"amount":672647500,"amplitude":0.027354,"askPrice":93.6,"askSize":6000,"bidPrice":93.55,"bidSize":2000,"shortable":3,"etf":0,"ttmEps":-1.2363672655500142,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789090200000},"marketStatusCode":5,"adr":0,"listingDate":1587657600000,"exchange":"SEHK","adjPreClose":95.05,"openAndCloseTimeList":[[1789003800000,1789012800000],[1789016400000,1789027200000]],"volumeRatio":0.46416,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"AKS.HK","impliedVol":0.6956,"impliedVolPercentile":0.7044},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09926\",,,,,undefined,":{"symbol":"09926","floatShares":921000000,"roa":"-4.57%","roe":"-13.59%","lyrEps":-1.441317,"volumeRatio":0.46416,"shares":921000000,"dividePrice":0,"high":96,"amplitude":0.027354,"preClose":95.05,"low":93.4,"week52Low":80.2,"pbRate":"8.69","psRate":"21.37","week52High":156,"institutionHeld":0,"latestPrice":93.6,"committee":-0.5,"eps":-1.4413165975581068,"divideRate":0,"volume":7151000,"delay":0,"ttmEps":-1.2363672655500142,"open":95.05,"prevYearClose":113,"prevWeekClose":101.2,"prevMonthClose":89.9,"prevQuarterClose":88.05,"fiveDayClose":90.8,"twentyDayClose":103.6,"sixtyDayClose":84.65},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/09926\",params:#limit:5,,,undefined,":[{"date":"2026-08-27","symbol":"09926","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787794200000,"name":null,"time":"","dateTimestamp":1787760000000,"actualEps":null},{"date":"2026-03-26","symbol":"09926","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774488600000,"name":null,"time":"","dateTimestamp":1774454400000,"actualEps":null},{"date":"2025-08-26","symbol":"09926","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null},{"date":"2025-03-30","symbol":"09926","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743298200000,"name":null,"time":"Post-Mkt","dateTimestamp":1743264000000,"actualEps":null},{"date":"2024-08-28","symbol":"09926","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724808600000,"name":null,"time":"","dateTimestamp":1724774400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"09926\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"09926\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.56,"hold":0.04,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.56,"analysts":25,"updateTime":1786723200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/09926\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"09926","date":"2026-09-09","current":-75.70566,"percent":0.268949,"low":-283.614883,"twenty":-99.277979,"median":-26.442363,"eighty":13.158791,"high":20.221708,"avg":-48.526078,"sd":59.133731,"marketCap":87554658878},"quantilePoints":[{"date":"2021-09-10","current":-32.055246,"twenty":-59.359698,"median":-34.971061,"eighty":-23.122707,"marketCap":35950515744},{"date":"2021-09-17","current":-31.163903,"twenty":-59.210176,"median":-34.572405,"eighty":-23.198629,"marketCap":34847488556},{"date":"2021-09-24","current":-31.295563,"twenty":-59.102123,"median":-34.437371,"eighty":-23.212212,"marketCap":35010899991},{"date":"2021-09-30","current":-31.154784,"twenty":-59.047908,"median":-34.407249,"eighty":-23.447883,"marketCap":34970047132},{"date":"2021-10-08","current":-29.845898,"twenty":-58.976264,"median":-34.085183,"eighty":-24.385279,"marketCap":33499344216},{"date":"2021-10-15","current":-32.807984,"twenty":-58.969537,"median":-33.89682,"eighty":-24.581853,"marketCap":36849278637},{"date":"2021-10-22","current":-33.585285,"twenty":-58.897857,"median":-33.786096,"eighty":-24.856047,"marketCap":37993158684},{"date":"2021-10-29","current":-31.568779,"twenty":-58.531823,"median":-33.627637,"eighty":-25.019036,"marketCap":35623692873},{"date":"2021-11-05","current":-28.336247,"twenty":-58.387259,"median":-33.581277,"eighty":-25.13981,"marketCap":32028641299},{"date":"2021-11-12","current":-31.135474,"twenty":-58.165915,"median":-33.566565,"eighty":-25.305935,"marketCap":35337722862},{"date":"2021-11-19","current":-36.658551,"twenty":-57.747713,"median":-33.576384,"eighty":-25.505551,"marketCap":41547357399},{"date":"2021-11-26","current":-34.737009,"twenty":-57.465203,"median":-33.61015,"eighty":-25.671516,"marketCap":39382155883},{"date":"2021-12-03","current":-31.939354,"twenty":-57.376977,"median":-33.627637,"eighty":-26.141756,"marketCap":36277338614},{"date":"2021-12-10","current":-30.771813,"twenty":-57.264113,"median":-33.577269,"eighty":-26.43668,"marketCap":35010899991},{"date":"2021-12-17","current":-26.05017,"twenty":-56.996271,"median":-33.456271,"eighty":-26.43668,"marketCap":29618322630},{"date":"2021-12-24","current":-24.338156,"twenty":-56.834726,"median":-33.106388,"eighty":-25.505551,"marketCap":27698238266},{"date":"2021-12-31","current":-24.356969,"twenty":-56.799582,"median":-33.044261,"eighty":-25.17902,"marketCap":27779943984},{"date":"2022-01-07","current":-20.242995,"twenty":-23.086945,"median":-21.779811,"eighty":-19.899701,"marketCap":23000159504},{"date":"2022-01-14","current":-20.701287,"twenty":-22.600464,"median":-21.033383,"eighty":-20.391327,"marketCap":23572099527},{"date":"2022-01-21","current":-18.577865,"twenty":-21.986595,"median":-20.680988,"eighty":-19.350843,"marketCap":21202633717},{"date":"2022-01-28","current":-14.534275,"twenty":-21.562934,"median":-20.260299,"eighty":-18.52558,"marketCap":16545407814},{"date":"2022-02-04","current":-14.146452,"twenty":-21.41835,"median":-20.123216,"eighty":-17.613539,"marketCap":16096026367},{"date":"2022-02-11","current":-13.816944,"twenty":-21.209422,"median":-19.299968,"eighty":-14.985471,"marketCap":15752862353},{"date":"2022-02-18","current":-13.849256,"twenty":-20.857344,"median":-18.911796,"eighty":-14.543623,"marketCap":15867250357},{"date":"2022-02-25","current":-14.199347,"twenty":-20.701287,"median":-17.613539,"eighty":-14.146452,"marketCap":16308461232},{"date":"2022-03-04","current":-14.080132,"twenty":-20.680988,"median":-15.318994,"eighty":-14.146452,"marketCap":16177732084},{"date":"2022-03-11","current":-11.936356,"twenty":-20.490215,"median":-14.985471,"eighty":-13.996814,"marketCap":13693878269},{"date":"2022-03-18","current":-11.726724,"twenty":-20.277602,"median":-14.700549,"eighty":-13.379502,"marketCap":13399737686},{"date":"2022-03-25","current":-12.670051,"twenty":-20.242995,"median":-14.554967,"eighty":-13.072377,"marketCap":14478253158},{"date":"2022-04-01","current":-9.59311,"twenty":-20.003436,"median":-14.538949,"eighty":-12.331764,"marketCap":12697068515},{"date":"2022-04-08","current":-10.156641,"twenty":-19.508494,"median":-14.196743,"eighty":-11.833638,"marketCap":13448761116},{"date":"2022-04-14","current":-9.530673,"twenty":-19.333884,"median":-14.131899,"eighty":-11.51878,"marketCap":12599021653},{"date":"2022-04-22","current":-8.780037,"twenty":-19.299831,"median":-14.060726,"eighty":-10.573986,"marketCap":11389777033},{"date":"2022-04-29","current":-9.576611,"twenty":-19.278065,"median":-13.849256,"eighty":-10.115287,"marketCap":12223175352},{"date":"2022-05-06","current":-7.86231,"twenty":-19.112154,"median":-13.498553,"eighty":-9.579911,"marketCap":9951756403},{"date":"2022-05-13","current":-8.110711,"twenty":-18.577865,"median":-13.379502,"eighty":-9.437455,"marketCap":10082485551},{"date":"2022-05-20","current":-9.061494,"twenty":-18.447152,"median":-13.096379,"eighty":-8.947629,"marketCap":11422459320},{"date":"2022-05-27","current":-8.809867,"twenty":-17.613539,"median":-12.670051,"eighty":-8.780037,"marketCap":11095636450},{"date":"2022-06-02","current":-11.227787,"twenty":-16.802517,"median":-12.331764,"eighty":-8.803901,"marketCap":14216794862},{"date":"2022-06-10","current":-12.109337,"twenty":-15.675042,"median":-12.221978,"eighty":-8.825148,"marketCap":15229945760},{"date":"2022-06-17","current":-11.667379,"twenty":-15.244074,"median":-11.936356,"eighty":-8.923897,"marketCap":14658005737},{"date":"2022-06-24","current":-16.485913,"twenty":-15.494316,"median":-12.221978,"eighty":-9.038721,"marketCap":20794105129},{"date":"2022-06-30","current":-14.957001,"twenty":-15.895364,"median":-12.380422,"eighty":-9.079607,"marketCap":18833167906},{"date":"2022-07-08","current":-15.913959,"twenty":-16.531452,"median":-12.638751,"eighty":-9.104893,"marketCap":20058753670},{"date":"2022-07-15","current":-15.322331,"twenty":-16.45611,"median":-12.887919,"eighty":-9.149933,"marketCap":19134050754},{"date":"2022-07-22","current":-14.807486,"twenty":-16.221667,"median":-13.200862,"eighty":-9.216155,"marketCap":18503257872},{"date":"2022-07-29","current":-14.117198,"twenty":-15.979822,"median":-13.449665,"eighty":-9.360153,"marketCap":17662200696},{"date":"2022-08-05","current":-15.298986,"twenty":-15.838747,"median":-13.498553,"eighty":-9.442,"marketCap":19091997895},{"date":"2022-08-12","current":-15.143556,"twenty":-15.77936,"median":-13.923035,"eighty":-9.496416,"marketCap":18923786460},{"date":"2022-08-19","current":-14.616817,"twenty":-15.77936,"median":-14.080132,"eighty":-9.558236,"marketCap":18082729284},{"date":"2022-08-26","current":-14.756101,"twenty":-15.738632,"median":-14.060726,"eighty":-9.58651,"marketCap":21573116564},{"date":"2022-09-02","current":-14.751536,"twenty":-15.714766,"median":-14.080132,"eighty":-9.724865,"marketCap":21489010846},{"date":"2022-09-09","current":-14.98178,"twenty":-15.703366,"median":-14.105484,"eighty":-9.977712,"marketCap":21741327999},{"date":"2022-09-16","current":-13.542084,"twenty":-15.658514,"median":-14.086951,"eighty":-10.115287,"marketCap":19470473624},{"date":"2022-09-23","current":-12.107338,"twenty":-15.550768,"median":-14.041319,"eighty":-10.199224,"marketCap":17073460672},{"date":"2022-09-30","current":-12.91765,"twenty":-15.461818,"median":-13.978573,"eighty":-10.287783,"marketCap":18250940719},{"date":"2022-10-07","current":-16.281937,"twenty":-15.588998,"median":-14.018764,"eighty":-10.343921,"marketCap":23002913763},{"date":"2022-10-14","current":-15.674276,"twenty":-15.588998,"median":-14.040715,"eighty":-10.440625,"marketCap":21909539434},{"date":"2022-10-21","current":-18.781307,"twenty":-15.710601,"median":-14.070137,"eighty":-10.570074,"marketCap":26072772456},{"date":"2022-10-28","current":-18.085263,"twenty":-15.888888,"median":-14.117198,"eighty":-10.76408,"marketCap":25063503844},{"date":"2022-11-04","current":-18.001131,"twenty":-16.380537,"median":-14.170295,"eighty":-10.773453,"marketCap":25189662421},{"date":"2022-11-11","current":-17.246398,"twenty":-16.644748,"median":-14.199347,"eighty":-10.843556,"marketCap":24348605245},{"date":"2022-11-18","current":-21.310798,"twenty":-17.050284,"median":-14.308051,"eighty":-11.043704,"marketCap":29983688324},{"date":"2022-11-25","current":-18.980602,"twenty":-17.498612,"median":-14.382807,"eighty":-11.22006,"marketCap":26493301044},{"date":"2022-12-02","current":-19.013979,"twenty":-17.995008,"median":-14.534799,"eighty":-11.242055,"marketCap":26997935349},{"date":"2022-12-09","current":-24.062263,"twenty":-18.437795,"median":-14.543856,"eighty":-11.359054,"marketCap":34483344216},{"date":"2022-12-16","current":-24.530301,"twenty":-18.889555,"median":-14.574904,"eighty":-11.602588,"marketCap":35072084239},{"date":"2022-12-23","current":-25.228352,"twenty":-19.041941,"median":-14.612379,"eighty":-11.627361,"marketCap":36081352850},{"date":"2022-12-30","current":-24.983629,"twenty":-19.09779,"median":-14.616563,"eighty":-11.655751,"marketCap":36165458568},{"date":"2023-01-06","current":-26.109825,"twenty":-19.246994,"median":-14.727609,"eighty":-11.666513,"marketCap":38183995790},{"date":"2023-01-13","current":-27.482086,"twenty":-19.35432,"median":-14.788719,"eighty":-11.675194,"marketCap":40959484471},{"date":"2023-01-20","current":-27.207673,"twenty":-19.72973,"median":-14.927803,"eighty":-11.681264,"marketCap":40202533012},{"date":"2023-01-27","current":-29.02317,"twenty":-19.973183,"median":-14.953302,"eighty":-11.681837,"marketCap":42893915976},{"date":"2023-02-03","current":-27.684735,"twenty":-20.135985,"median":-14.979187,"eighty":-11.694899,"marketCap":41127695906},{"date":"2023-02-10","current":-25.345976,"twenty":-20.490215,"median":-14.987339,"eighty":-11.726724,"marketCap":37427044332},{"date":"2023-02-17","current":-24.322978,"twenty":-20.857344,"median":-15.034554,"eighty":-11.784491,"marketCap":35576718544},{"date":"2023-02-24","current":-24.100109,"twenty":-21.41835,"median":-15.060613,"eighty":-11.860367,"marketCap":34819767086},{"date":"2023-03-03","current":-25.36278,"twenty":-22.807081,"median":-15.131721,"eighty":-11.936356,"marketCap":36880357167},{"date":"2023-03-10","current":-22.900092,"twenty":-23.768741,"median":-23.203261,"eighty":-23.03994,"marketCap":33053547016},{"date":"2023-03-17","current":-29.09369,"twenty":-36.802165,"median":-25.36278,"eighty":-15.020812,"marketCap":38688630096},{"date":"2023-03-24","current":-25.324343,"twenty":-36.777216,"median":-25.389232,"eighty":-15.036479,"marketCap":34062815628},{"date":"2023-03-31","current":-25.456261,"twenty":-36.704597,"median":-25.488573,"eighty":-15.049117,"marketCap":33978709910},{"date":"2023-04-06","current":-27.774061,"twenty":-36.623868,"median":-25.540624,"eighty":-15.058257,"marketCap":37048568602},{"date":"2023-04-14","current":-29.730818,"twenty":-36.485136,"median":-25.637411,"eighty":-15.064541,"marketCap":39697898707},{"date":"2023-04-21","current":-26.784111,"twenty":-36.470425,"median":-25.724076,"eighty":-15.129637,"marketCap":35744929980},{"date":"2023-04-28","current":-27.207269,"twenty":-36.436465,"median":-26.010547,"eighty":-15.131721,"marketCap":36039299991},{"date":"2023-05-05","current":-28.335447,"twenty":-36.311562,"median":-26.064869,"eighty":-15.141189,"marketCap":37595255767},{"date":"2023-05-12","current":-27.159579,"twenty":-36.18971,"median":-26.086367,"eighty":-15.143863,"marketCap":35786982838},{"date":"2023-05-19","current":-24.342298,"twenty":-36.161524,"median":-26.085247,"eighty":-15.156,"marketCap":31623749817},{"date":"2023-05-25","current":-24.063272,"twenty":-36.158475,"median":-26.064869,"eighty":-15.180082,"marketCap":31203221229},{"date":"2023-06-02","current":-23.645458,"twenty":-36.149195,"median":-25.984476,"eighty":-15.257042,"marketCap":30488322630},{"date":"2023-06-09","current":-23.222359,"twenty":-36.112659,"median":-25.723039,"eighty":-15.312993,"marketCap":29899582606},{"date":"2023-06-16","current":-24.58122,"twenty":-36.07905,"median":-25.633881,"eighty":-15.343575,"marketCap":31497591241},{"date":"2023-06-23","current":-21.944137,"twenty":-36.043198,"median":-25.488573,"eighty":-15.365065,"marketCap":27965151102},{"date":"2023-06-30","current":-23.543047,"twenty":-35.998611,"median":-25.389232,"eighty":-15.403178,"marketCap":29731371171},{"date":"2023-07-07","current":-23.989446,"twenty":-35.969849,"median":-25.36278,"eighty":-15.455833,"marketCap":30236005477},{"date":"2023-07-14","current":-24.41425,"twenty":-35.912278,"median":-25.312393,"eighty":-15.498928,"marketCap":31203221229},{"date":"2023-07-21","current":-24.59436,"twenty":-35.843663,"median":-25.202538,"eighty":-15.562817,"marketCap":31287326947},{"date":"2023-07-28","current":-28.426335,"twenty":-35.766034,"median":-25.264398,"eighty":-15.623426,"marketCap":36123405709},{"date":"2023-08-04","current":-24.11733,"twenty":-35.704573,"median":-25.300444,"eighty":-15.66297,"marketCap":30698586924},{"date":"2023-08-11","current":-22.294,"twenty":-35.666275,"median":-25.201022,"eighty":-15.683018,"marketCap":28217468254},{"date":"2023-08-18","current":-21.752014,"twenty":-35.64615,"median":-25.173816,"eighty":-15.703366,"marketCap":27334358220},{"date":"2023-08-25","current":-22.10921,"twenty":-35.616771,"median":-25.07893,"eighty":-15.714766,"marketCap":27796939666},{"date":"2023-09-01","current":13.494719,"twenty":-35.601124,"median":-25.008455,"eighty":-15.66297,"marketCap":28974419713},{"date":"2023-09-08","current":13.695117,"twenty":-35.550756,"median":-24.944029,"eighty":-15.455833,"marketCap":29058525430},{"date":"2023-09-15","current":14.848421,"twenty":-35.47221,"median":-24.903626,"eighty":-15.308324,"marketCap":31749908394},{"date":"2023-09-22","current":14.814862,"twenty":-35.438003,"median":-24.827647,"eighty":-15.14371,"marketCap":31539644100},{"date":"2023-09-29","current":14.197918,"twenty":-35.396385,"median":-24.772153,"eighty":-15.059828,"marketCap":30278058336},{"date":"2023-10-06","current":13.889059,"twenty":-35.370319,"median":-24.700469,"eighty":-15.007069,"marketCap":29605212595},{"date":"2023-10-13","current":15.431226,"twenty":-35.30592,"median":-24.632761,"eighty":-14.979706,"marketCap":32843282722},{"date":"2023-10-20","current":14.94053,"twenty":-35.232247,"median":-24.59436,"eighty":-14.914724,"marketCap":31749908394},{"date":"2023-10-27","current":16.35255,"twenty":-35.175876,"median":-24.58122,"eighty":-14.756101,"marketCap":34735661368},{"date":"2023-11-03","current":17.592659,"twenty":-35.129074,"median":-24.511377,"eighty":-14.616308,"marketCap":37469097190},{"date":"2023-11-10","current":18.939266,"twenty":-34.971061,"median":-24.417444,"eighty":-14.569406,"marketCap":40328691589},{"date":"2023-11-17","current":18.319814,"twenty":-34.968612,"median":-24.399566,"eighty":-14.535322,"marketCap":39361475836},{"date":"2023-11-24","current":18.189638,"twenty":-34.895357,"median":-24.342298,"eighty":-14.371526,"marketCap":39403528695},{"date":"2023-12-01","current":18.752497,"twenty":-34.737009,"median":-24.330293,"eighty":-14.199347,"marketCap":40791273036},{"date":"2023-12-08","current":16.771041,"twenty":-34.685609,"median":-24.255162,"eighty":-14.117346,"marketCap":36333670003},{"date":"2023-12-15","current":17.832719,"twenty":-34.615488,"median":-24.15298,"eighty":-14.060142,"marketCap":38856841531},{"date":"2023-12-22","current":16.203086,"twenty":-34.602221,"median":-24.100109,"eighty":-13.960331,"marketCap":35282348533},{"date":"2023-12-29","current":17.826838,"twenty":-34.566441,"median":-24.075355,"eighty":-13.84838,"marketCap":39025052966},{"date":"2024-01-05","current":16.831364,"twenty":-34.502078,"median":-24.025855,"eighty":-13.7643,"marketCap":36585987156},{"date":"2024-01-12","current":17.634525,"twenty":-34.43816,"median":-23.91516,"eighty":-13.515965,"marketCap":38352207225},{"date":"2024-01-19","current":16.051677,"twenty":-34.428025,"median":-23.817977,"eighty":-13.388012,"marketCap":34861819945},{"date":"2024-01-26","current":16.269899,"twenty":-34.417805,"median":-23.667454,"eighty":-13.261099,"marketCap":35198242815},{"date":"2024-02-02","current":15.531605,"twenty":-34.408725,"median":-23.587311,"eighty":-13.092715,"marketCap":33558181322},{"date":"2024-02-09","current":15.823479,"twenty":-34.287198,"median":-23.509747,"eighty":-12.88456,"marketCap":34357185639},{"date":"2024-02-16","current":17.001239,"twenty":-34.118192,"median":-23.29296,"eighty":-12.670051,"marketCap":36922410026},{"date":"2024-02-23","current":17.733723,"twenty":-34.052175,"median":-23.261464,"eighty":-12.429079,"marketCap":38310154366},{"date":"2024-03-01","current":18.170113,"twenty":-33.918444,"median":-23.222586,"eighty":-12.109337,"marketCap":39277370119},{"date":"2024-03-08","current":18.375936,"twenty":-33.875196,"median":-23.212231,"eighty":-11.784491,"marketCap":39739951566},{"date":"2024-03-15","current":20.221708,"twenty":-33.786096,"median":-23.186995,"eighty":-11.680404,"marketCap":43692920293},{"date":"2024-03-22","current":17.596046,"twenty":-33.777607,"median":-23.165857,"eighty":-11.598761,"marketCap":38772735813},{"date":"2024-03-28","current":17.863111,"twenty":-33.671621,"median":-23.133172,"eighty":-11.174522,"marketCap":39235317260},{"date":"2024-04-05","current":17.790526,"twenty":-33.631134,"median":-23.073507,"eighty":-10.781195,"marketCap":39050158637},{"date":"2024-04-12","current":19.515107,"twenty":-33.600204,"median":-23.002422,"eighty":-10.363031,"marketCap":42859930212},{"date":"2024-04-19","current":17.322126,"twenty":-33.582079,"median":-22.887987,"eighty":-9.922708,"marketCap":38011130026},{"date":"2024-04-26","current":19.239838,"twenty":-33.576561,"median":-22.815578,"eighty":-9.479287,"marketCap":42167244471},{"date":"2024-05-03","current":19.371749,"twenty":-33.573712,"median":-22.807081,"eighty":-9.18811,"marketCap":42427001624},{"date":"2024-05-10","current":19.700553,"twenty":-33.522448,"median":-22.755385,"eighty":-8.970402,"marketCap":43249565941},{"date":"2024-05-17","current":19.23578,"twenty":-33.345978,"median":-22.735553,"eighty":-8.780037,"marketCap":42167244471},{"date":"2024-05-24","current":14.667701,"twenty":-33.217784,"median":-22.607363,"eighty":-8.675073,"marketCap":32080008370},{"date":"2024-05-31","current":17.401421,"twenty":-33.106388,"median":-22.460124,"eighty":-8.554056,"marketCap":38097715744},{"date":"2024-06-07","current":16.096502,"twenty":-33.061925,"median":-22.417733,"eighty":-8.291628,"marketCap":35197094204},{"date":"2024-06-14","current":15.794192,"twenty":-33.047794,"median":-22.339227,"eighty":-8.117822,"marketCap":34504408463},{"date":"2024-06-21","current":14.159201,"twenty":-33.01008,"median":-22.315076,"eighty":-7.860137,"marketCap":30867808324},{"date":"2024-06-28","current":14.999486,"twenty":-32.90826,"median":-22.280642,"eighty":13.494356,"marketCap":32686108394},{"date":"2024-07-05","current":15.459781,"twenty":-32.881624,"median":-22.258985,"eighty":13.627238,"marketCap":33681844146},{"date":"2024-07-12","current":15.952998,"twenty":-32.86657,"median":-22.065202,"eighty":13.703744,"marketCap":34807458475},{"date":"2024-07-19","current":15.972541,"twenty":-32.832239,"median":-21.944137,"eighty":13.863497,"marketCap":34850751334},{"date":"2024-07-26","current":16.071567,"twenty":-32.814226,"median":-21.7966,"eighty":14.148348,"marketCap":35197094204},{"date":"2024-08-02","current":16.61499,"twenty":-32.811697,"median":-21.752014,"eighty":14.411832,"marketCap":36366001392},{"date":"2024-08-09","current":17.212345,"twenty":-32.808943,"median":-21.597174,"eighty":14.509977,"marketCap":37924544308},{"date":"2024-08-16","current":17.657405,"twenty":-32.804956,"median":-21.439655,"eighty":14.640353,"marketCap":38920280061},{"date":"2024-08-23","current":17.9547,"twenty":-32.79969,"median":-21.418042,"eighty":14.703604,"marketCap":39742844378},{"date":"2024-08-30","current":-52.624506,"twenty":-32.804956,"median":-21.417734,"eighty":14.818346,"marketCap":42513587341},{"date":"2024-09-06","current":-51.635037,"twenty":-32.832239,"median":-21.438942,"eighty":14.78042,"marketCap":41734315883},{"date":"2024-09-13","current":-66.216902,"twenty":-33.018625,"median":-21.520592,"eighty":14.703604,"marketCap":53380094900},{"date":"2024-09-20","current":-69.932725,"twenty":-33.173226,"median":-21.714319,"eighty":14.662246,"marketCap":56713645028},{"date":"2024-09-27","current":-71.531113,"twenty":-33.576561,"median":-21.771586,"eighty":14.652247,"marketCap":58358773662},{"date":"2024-10-04","current":-79.320454,"twenty":-33.638129,"median":-21.813706,"eighty":14.649255,"marketCap":64419773894},{"date":"2024-10-10","current":-69.213885,"twenty":-33.875196,"median":-21.986037,"eighty":14.648182,"marketCap":55847787852},{"date":"2024-10-18","current":-74.646599,"twenty":-34.399868,"median":-22.081407,"eighty":14.635134,"marketCap":59917316579},{"date":"2024-10-25","current":-77.719883,"twenty":-34.441314,"median":-22.265924,"eighty":14.560741,"marketCap":62380223732},{"date":"2024-11-01","current":-76.214752,"twenty":-34.685609,"median":-22.294,"eighty":14.556702,"marketCap":61213399403},{"date":"2024-11-08","current":-76.2814,"twenty":-34.971061,"median":-22.333531,"eighty":14.515997,"marketCap":60989010109},{"date":"2024-11-15","current":-78.00551,"twenty":-35.320815,"median":-22.40582,"eighty":14.505964,"marketCap":61707055850},{"date":"2024-11-22","current":-81.958791,"twenty":-35.480573,"median":-22.437728,"eighty":14.479729,"marketCap":64803628107},{"date":"2024-11-29","current":-83.036127,"twenty":-35.659842,"median":-22.470599,"eighty":14.463817,"marketCap":65611429565},{"date":"2024-12-06","current":-74.237179,"twenty":-35.878177,"median":-22.720101,"eighty":14.435399,"marketCap":58520727875},{"date":"2024-12-13","current":-72.615659,"twenty":-36.070462,"median":-22.745547,"eighty":14.396121,"marketCap":57129514252},{"date":"2024-12-20","current":-69.730236,"twenty":-36.160141,"median":-22.79318,"eighty":14.28027,"marketCap":54616354159},{"date":"2024-12-27","current":-68.121477,"twenty":-36.342788,"median":-22.81524,"eighty":14.230859,"marketCap":53314896254},{"date":"2025-01-03","current":-66.794572,"twenty":-36.589185,"median":-22.863096,"eighty":14.182431,"marketCap":52327583360},{"date":"2025-01-10","current":-64.575988,"twenty":-36.921451,"median":-22.916115,"eighty":14.151966,"marketCap":50397835432},{"date":"2025-01-17","current":-67.97132,"twenty":-37.388459,"median":-23.037405,"eighty":14.124517,"marketCap":53090506960},{"date":"2025-01-24","current":-71.487894,"twenty":-37.630978,"median":-23.112092,"eighty":14.06824,"marketCap":56187079217},{"date":"2025-01-28","current":-69.159217,"twenty":-37.749998,"median":-23.133265,"eighty":14.036856,"marketCap":54616354159},{"date":"2025-02-07","current":-74.204707,"twenty":-38.720974,"median":-23.179575,"eighty":13.91548,"marketCap":58296338581},{"date":"2025-02-14","current":-68.942526,"twenty":-39.742666,"median":-23.199597,"eighty":13.854976,"marketCap":54032941995},{"date":"2025-02-21","current":-78.532535,"twenty":-40.936164,"median":-23.213534,"eighty":13.833941,"marketCap":61886567285},{"date":"2025-02-28","current":-83.363188,"twenty":-41.78603,"median":-23.229233,"eighty":13.752998,"marketCap":65476795989},{"date":"2025-03-07","current":-82.972913,"twenty":-43.765472,"median":-23.273351,"eighty":13.720056,"marketCap":65431918130},{"date":"2025-03-14","current":-81.918752,"twenty":-44.36559,"median":-23.404228,"eighty":13.69943,"marketCap":64624116672},{"date":"2025-03-21","current":-77.113549,"twenty":-46.703645,"median":-23.571971,"eighty":13.681934,"marketCap":60809498674},{"date":"2025-03-28","current":-85.082441,"twenty":-50.561624,"median":-23.656456,"eighty":13.67268,"marketCap":66957765329},{"date":"2025-04-03","current":-139.968555,"twenty":-51.651807,"median":-23.75284,"eighty":13.662257,"marketCap":77100161418},{"date":"2025-04-11","current":-135.149196,"twenty":-52.531592,"median":-23.854164,"eighty":13.627238,"marketCap":73779199867},{"date":"2025-04-17","current":-136.201828,"twenty":-53.202931,"median":-23.974596,"eighty":13.597708,"marketCap":74452367749},{"date":"2025-04-25","current":-162.080631,"twenty":-54.264543,"median":-23.982021,"eighty":13.592632,"marketCap":88770184906},{"date":"2025-05-02","current":-143.58439,"twenty":-55.295104,"median":-23.989446,"eighty":13.587555,"marketCap":78807100452},{"date":"2025-05-09","current":-136.980788,"twenty":-56.345373,"median":-23.982021,"eighty":13.592632,"marketCap":75710466095},{"date":"2025-05-16","current":-134.501562,"twenty":-57.376977,"median":-23.982021,"eighty":13.592632,"marketCap":74947527196},{"date":"2025-05-23","current":-133.538341,"twenty":-57.747713,"median":-23.982021,"eighty":13.592632,"marketCap":74633375884},{"date":"2025-05-30","current":-133.993142,"twenty":-58.91872,"median":-23.982021,"eighty":13.592632,"marketCap":75216799748},{"date":"2025-06-06","current":-131.180073,"twenty":-59.359698,"median":-23.982021,"eighty":13.592632,"marketCap":73825558226},{"date":"2025-06-13","current":-152.810216,"twenty":-59.540166,"median":-23.982021,"eighty":13.592632,"marketCap":86032580619},{"date":"2025-06-20","current":-145.842175,"twenty":-59.540166,"median":-23.982021,"eighty":13.592632,"marketCap":81948613568},{"date":"2025-06-27","current":-147.346424,"twenty":-59.773257,"median":-23.989446,"eighty":13.587555,"marketCap":83025703780},{"date":"2025-07-04","current":-184.930979,"twenty":-59.773257,"median":-23.989446,"eighty":13.587555,"marketCap":104208477933},{"date":"2025-07-11","current":-180.493504,"twenty":-59.773257,"median":-23.989446,"eighty":13.587555,"marketCap":101605509923},{"date":"2025-07-18","current":-224.51725,"twenty":-59.773257,"median":-23.989446,"eighty":13.587555,"marketCap":126288827263},{"date":"2025-07-25","current":-237.059172,"twenty":-59.773257,"median":-23.989446,"eighty":13.587555,"marketCap":133828458741},{"date":"2025-08-01","current":-250.051759,"twenty":-59.773257,"median":-23.989446,"eighty":13.587555,"marketCap":140291000008},{"date":"2025-08-08","current":-255.97072,"twenty":-59.773257,"median":-23.989446,"eighty":13.587555,"marketCap":143971058230},{"date":"2025-08-15","current":-264.505775,"twenty":-59.98102,"median":-23.989446,"eighty":13.587555,"marketCap":148548691628},{"date":"2025-08-22","current":-283.614883,"twenty":-59.98102,"median":-23.989446,"eighty":13.587555,"marketCap":158781048634},{"date":"2025-08-29","current":-151.096607,"twenty":-60.061292,"median":-23.989446,"eighty":13.587555,"marketCap":139755257503},{"date":"2025-09-05","current":-154.217836,"twenty":-62.354796,"median":-23.989446,"eighty":13.587555,"marketCap":142500849327},{"date":"2025-09-12","current":-134.834957,"twenty":-64.590671,"median":-23.989446,"eighty":13.587555,"marketCap":124814900348},{"date":"2025-09-19","current":-129.155078,"twenty":-65.225568,"median":-24.062263,"eighty":13.587555,"marketCap":119472269927},{"date":"2025-09-26","current":-132.486221,"twenty":-66.989962,"median":-24.124656,"eighty":13.587555,"marketCap":122235699455},{"date":"2025-10-03","current":-139.242464,"twenty":-67.293654,"median":-24.261227,"eighty":13.582478,"marketCap":128775816004},{"date":"2025-10-10","current":-127.67557,"twenty":-67.910041,"median":-24.342298,"eighty":13.587555,"marketCap":117906326528},{"date":"2025-10-17","current":-122.384529,"twenty":-68.235995,"median":-24.417444,"eighty":13.587555,"marketCap":112932153377},{"date":"2025-10-24","current":-114.955731,"twenty":-68.842466,"median":-24.58122,"eighty":13.587555,"marketCap":106115693875},{"date":"2025-10-31","current":-112.991017,"twenty":-69.234459,"median":-24.630996,"eighty":13.587555,"marketCap":104457636158},{"date":"2025-11-07","current":-111.865223,"twenty":-69.783847,"median":-24.772153,"eighty":13.587555,"marketCap":103352264347},{"date":"2025-11-14","current":-118.110846,"twenty":-71.021734,"median":-24.903626,"eighty":13.587555,"marketCap":109431809308},{"date":"2025-11-21","current":-106.428879,"twenty":-71.496538,"median":-25.008455,"eighty":13.587555,"marketCap":98562319832},{"date":"2025-11-28","current":-121.801586,"twenty":-72.238759,"median":-25.173816,"eighty":13.587555,"marketCap":113208496330},{"date":"2025-12-05","current":-122.779771,"twenty":-72.794834,"median":-25.300444,"eighty":13.587555,"marketCap":114313868141},{"date":"2025-12-12","current":-122.948103,"twenty":-73.382927,"median":-25.403597,"eighty":13.587555,"marketCap":114682325412},{"date":"2025-12-19","current":-115.46697,"twenty":-74.211201,"median":-25.633881,"eighty":13.587555,"marketCap":107957980227},{"date":"2025-12-24","current":-110.590517,"twenty":-74.659967,"median":-25.640942,"eighty":13.587555,"marketCap":103720721617},{"date":"2026-01-02","current":-110.841788,"twenty":-75.482016,"median":-25.637411,"eighty":13.592632,"marketCap":104365521840},{"date":"2026-01-09","current":-124.521475,"twenty":-75.983701,"median":-25.679301,"eighty":13.547374,"marketCap":117537869257},{"date":"2026-01-16","current":-117.698232,"twenty":-76.738768,"median":-25.679301,"eighty":13.547374,"marketCap":111458324296},{"date":"2026-01-23","current":-113.429847,"twenty":-77.350039,"median":-25.679301,"eighty":13.547374,"marketCap":107313180004},{"date":"2026-01-30","current":-107.001444,"twenty":-78.004549,"median":-25.679301,"eighty":13.547374,"marketCap":101694206630},{"date":"2026-02-06","current":-97.546473,"twenty":-79.287468,"median":-25.773598,"eighty":13.494628,"marketCap":92943346458},{"date":"2026-02-13","current":-101.218847,"twenty":-80.266586,"median":-25.825195,"eighty":13.494537,"marketCap":96996376432},{"date":"2026-02-20","current":-105.022841,"twenty":-80.777808,"median":-25.722001,"eighty":13.494719,"marketCap":100496720501},{"date":"2026-02-27","current":-101.788736,"twenty":-81.405078,"median":-25.722001,"eighty":13.494719,"marketCap":98470205514},{"date":"2026-03-06","current":-102.999959,"twenty":-82.133452,"median":-25.722001,"eighty":13.494719,"marketCap":98838662784},{"date":"2026-03-13","current":-105.298763,"twenty":-83.363188,"median":-25.722001,"eighty":13.494719,"marketCap":101509977995},{"date":"2026-03-20","current":-110.878439,"twenty":-84.977693,"median":-25.773598,"eighty":13.494628,"marketCap":106484151145},{"date":"2026-03-27","current":-92.387071,"twenty":-90.917747,"median":-25.773598,"eighty":13.494628,"marketCap":116432497446},{"date":"2026-04-02","current":-102.201748,"twenty":-96.788708,"median":-25.773598,"eighty":13.494628,"marketCap":129420616228},{"date":"2026-04-10","current":-99.759281,"twenty":-97.56233,"median":-25.773598,"eighty":13.494628,"marketCap":127301986923},{"date":"2026-04-17","current":-108.953175,"twenty":-98.069701,"median":-25.773598,"eighty":13.494628,"marketCap":139092619576},{"date":"2026-04-24","current":-94.949835,"twenty":-99.339337,"median":-25.773598,"eighty":13.494628,"marketCap":121222441961},{"date":"2026-04-30","current":-97.955024,"twenty":-99.339337,"median":-25.773598,"eighty":13.494628,"marketCap":125091243300},{"date":"2026-05-08","current":-96.322328,"twenty":-99.339337,"median":-25.773598,"eighty":13.494628,"marketCap":123433185584},{"date":"2026-05-15","current":-86.175907,"twenty":-99.339337,"median":-25.773598,"eighty":13.494628,"marketCap":110721409755},{"date":"2026-05-22","current":-83.786417,"twenty":-99.331319,"median":-25.825195,"eighty":13.494537,"marketCap":107405294321},{"date":"2026-05-29","current":-84.570211,"twenty":-99.339337,"median":-25.773598,"eighty":13.494628,"marketCap":108787009085},{"date":"2026-06-05","current":-66.928875,"twenty":-99.331319,"median":-25.825195,"eighty":13.494537,"marketCap":86219001273},{"date":"2026-06-12","current":-65.829318,"twenty":-99.323302,"median":-25.904836,"eighty":13.494447,"marketCap":84745172192},{"date":"2026-06-18","current":-62.495243,"twenty":-99.315284,"median":-25.984476,"eighty":13.494356,"marketCap":80646085058},{"date":"2026-06-26","current":-59.753298,"twenty":-99.323302,"median":-25.904836,"eighty":13.494447,"marketCap":76731226560},{"date":"2026-07-03","current":-73.399324,"twenty":-99.315284,"median":-25.984476,"eighty":13.494356,"marketCap":94325061222},{"date":"2026-07-10","current":-69.793507,"twenty":-99.315284,"median":-25.984476,"eighty":13.494356,"marketCap":89581173866},{"date":"2026-07-17","current":-63.181388,"twenty":-99.315284,"median":-25.984476,"eighty":13.494356,"marketCap":81382999599},{"date":"2026-07-24","current":-71.139059,"twenty":-99.315284,"median":-25.984476,"eighty":13.494356,"marketCap":91653746012},{"date":"2026-07-31","current":-67.043638,"twenty":-99.323302,"median":-25.904836,"eighty":13.494447,"marketCap":86541401385},{"date":"2026-08-07","current":-71.222684,"twenty":-99.323302,"median":-25.904836,"eighty":13.494447,"marketCap":92114317600},{"date":"2026-08-14","current":-68.287327,"twenty":-99.323302,"median":-26.043394,"eighty":13.494447,"marketCap":88429744896},{"date":"2026-08-21","current":-64.055639,"twenty":-99.315284,"median":-26.109825,"eighty":13.494356,"marketCap":83133171634},{"date":"2026-08-28","current":-77.864086,"twenty":-99.292622,"median":-26.202149,"eighty":13.326528,"marketCap":87831001831},{"date":"2026-09-04","current":-82.608113,"twenty":-99.277979,"median":-26.442363,"eighty":13.158791,"marketCap":93219689411},{"date":"2026-09-09","current":-77.463974,"twenty":-99.277979,"median":-26.442363,"eighty":13.158791,"marketCap":87554658878}],"updateTime":1789037919798},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"09926\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1107791354","title":"Akeso Interim 2026 Results: Revenue Reaches RMB 1.81 Billion, Net Loss Narrows by 24.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=1107791354","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107791354?lang=en_us&edition=fundamental","pubTime":"2026-08-27 22:21","pubTimestamp":1787840496,"startTime":"0","endTime":"0","summary":"Akeso Inc. released unaudited results for the six months ended 30 June 2026. Revenue rose 27.92% year-on-year to RMB 1.81 billion, driven almost entirely by commercial sales of key oncology...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Akeso Interim 2026 Results: Revenue Reaches RMB 1.81 Billion, Net Loss Narrows by 24.0%","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09926"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662790083","title":"Akeso FY26 H1 Net Loss Narrows 23.98% to RMB 447.2 Million; Revenue Rises 27.92% to RMB 1.81 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2662790083","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662790083?lang=en_us&edition=fundamental","pubTime":"2026-08-27 22:00","pubTimestamp":1787839249,"startTime":"0","endTime":"0","summary":"Akeso FY26 H1 net loss narrows 23.98% to RMB 447.2 million; revenue rises 27.92% to RMB 1.81 billionAkeso posted revenue of RMB 1.81 billion, up 27.92% year over year, driven mainly by cadonilimab and","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL34jFkn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0417516571.SGD","LU0634319403.HKD","IE00B543WZ88.USD","LU0348767384.USD","LU2476274308.USD","LU2778985437.USD","LU0348735423.USD","LU0561508036.HKD","LU1961090484.USD","LU2399975544.HKD","LU1794554557.SGD","LU0417516902.SGD","LU0348827113.USD","LU2476274720.SGD","09926","LU0348766576.USD","LU1720050803.USD","LU2488822045.USD","LU0348783233.USD","LU0348784397.USD","LU0540923850.HKD","IE00B5MMRT66.SGD","BK1574","KURE","BK1161","LU0348825331.USD","IE00BPRC5H50.USD","LU0417516738.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185413400","title":"Akeso Surges Over 6% Intraday as Guosen Securities Initiates 'Outperform' Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1185413400","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185413400?lang=en_us&edition=fundamental","pubTime":"2026-08-27 11:01","pubTimestamp":1787799711,"startTime":"0","endTime":"0","summary":"Akeso (09926) climbed more than 6% during Wednesday's trading session before paring gains, last up 2.34% at HK$96.40 with turnover reaching HK$686 million.On August 26, Akeso announced that its phase...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1961090484.USD","LU0417516738.SGD","LU0561508036.HKD","BK0028","BK1574","IE00BPRC5H50.USD","LU2488822045.USD","LU0348825331.USD","BK0183","LU0348784397.USD","LU0348827113.USD","LU0417516571.SGD","LU0417516902.SGD","002736","09926","LU2778985437.USD","LU2476274308.USD","BK0188","LU1720050803.USD","LU0634319403.HKD","LU0348783233.USD","LU0348766576.USD","LU2399975544.HKD","LU0348735423.USD","LU1794554557.SGD","IE00B543WZ88.USD","BK1161","LU2476274720.SGD","BK0276","LU0540923850.HKD","KURE","LU0348767384.USD","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187410603","title":"Movement Alert｜AKESO Rises 3.03% in Regular Trading, Ivonescimab Biliary Tract Cancer Phase 3 Meets Primary OS Endpoint Amid Interim Results Release","url":"https://stock-news.laohu8.com/highlight/detail?id=1187410603","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187410603?lang=en_us&edition=fundamental","pubTime":"2026-08-27 09:43","pubTimestamp":1787795021,"startTime":"0","endTime":"0","summary":"On August 27, AKESO rose 3.03% in regular trading, trading at 97.65 HKD/share, with turnover of HKD 175 million.On the news front, the company announced on August 26 that its PD-1/VEGF bispecific...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"AKESO Surges on Ivonescimab Biliary Tract Cancer OS Win","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09926"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154655464","title":"Morning Market Wrap: Hong Kong Shares Rise 0.68% as Copper Stocks Take the Lead","url":"https://stock-news.laohu8.com/highlight/detail?id=1154655464","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154655464?lang=en_us&edition=fundamental","pubTime":"2026-08-26 12:07","pubTimestamp":1787717221,"startTime":"0","endTime":"0","summary":"Hong Kong's benchmark index kicked off the morning session with a 0.68% gain, advancing 174 points to reach 25,685 points, while the tech-heavy Hang Seng Tech Index climbed a more robust 1.58%....","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348825331.USD","03419","LU1813983027.USD","07200","BK1521","BK1242","BK1592","603083","IE00BZ08YT58.USD","LU0181495838.USD","LU1188198961.HKD","BK1597","03908","LU0862451837.USD","LU1102505762.USD","LU0244354667.USD","BK1564","01258","IE00B543WZ88.USD","688185","IE00BGHQDM52.EUR","LU1048596156.SGD","LU2488822045.USD","02800","LU0320764599.SGD","LU0348767384.USD","600362","BK1240","BK1574","BK1501","601995","BK1513","BK1190","HK0000286598.CNH","03423","LU0561508036.HKD","LU0405327494.USD","BK1206","IE00B031HY20.USD","02575","06166","LU0359201612.USD","LU1102505929.USD","SG9999014674.SGD","LU0314109678.HKD","LU0594300419.USD","HSTECH","LU2351347302.SGD","LU0463099449.HKD","LU0634319403.HKD","07500","07552","BK1580","03115","07300","BK1149","HSI","BK1589","HHImain","LU0348784397.USD","SG9999004220.SGD","MCHmain","LU0405327148.USD","LU0650527681.SGD","LU0594300179.USD","LU0359202008.SGD","LU2929501877.USD","LU0140636845.USD","LU0149534421.HKD","03993","IE00BZ08YS42.EUR","BK1161","LU0164880469.USD","02313","LU2476274720.SGD","BK1594","BK1516","BK1237","LU0348766576.USD","IE00BVYPNP33.GBP","LU0326950275.SGD","LU0821914370.USD","LU1720050803.USD","LU0348783233.USD","LU1961090484.USD","06099","LU1880383366.USD","BK1184","LU0052750758.USD","LU0540923850.HKD","IE00BYV24P56.USD","600999","IE00BPRC5H50.USD","LU1794554557.SGD","LU0359201885.HKD","03088","BK1515","HTImain","IE0008369823.USD","03033","IE00BVYPNQ40.USD","LU0348735423.USD","HSImain","09115","LU0149721374.USD","00358","BK1147","LU0862451753.SGD","83115","06185","LU0708995583.HKD","LU2125910500.SGD","IE00BMCWC346.EUR","LU2039709279.SGD","LU0828237940.HKD","02837","513600","LU0607220059.USD","LU1481107354.HKD","01112","LU1831875114.USD","LU0605514214.HKD","03067","LU1328277881.USD","LU2399975544.HKD","IE00BZ08YR35.GBP","06831","09067","BK1191","01828","BK1553","SG9999002828.SGD","IE0031814852.USD","LU0890818403.SGD","07226","SG9999004311.SGD","BK1233","LU2187417386.USD","06969","09926","BK1568","IE0008368742.USD","LU1880383440.USD","KURE","02833","LU1023057109.AUD","SG9999002950.SGD","LU0417516571.SGD","03032","IE00B031J352.USD","IE00B5MMRT66.SGD","03037","LU0348827113.USD","82800","LU2045819591.USD","LU2213484517.USD","09088","03417","LU2476274308.USD","LU0417516902.SGD","IE00B29SXG58.USD","603993","BK1227","LU2778985437.USD","LU0417516738.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662769060","title":"China's Akeso Jumps on Progress of Immunotherapy Drug for Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2662769060","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662769060?lang=en_us&edition=fundamental","pubTime":"2026-08-26 10:33","pubTimestamp":1787711596,"startTime":"0","endTime":"0","summary":"BUZZ-China's Akeso jumps on progress of immunotherapy drug for cancer treatment** Shares of China-based drug developer Akeso Inc9926.HKjump 9% to HK$96.9, on track for the biggest one-day pct gain since June 29** Stock hits the highest level since August 20 in the second gaining session** Akeso saysivonescimab plus chemomeets primary endpoint with significant overall survival benefit versus durvalumab plus chemo in phase III clinical study for the first-line treatment of advanced biliary tract cancer** The study met all key secondary endpoints of progression-free survival and objective response rate - Co** YTD, stock down 14.8%, while Hang Seng Biotech Index.HSBIOup 15.7%","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N025:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348766576.USD","IE00BPRC5H50.USD","LU0540923850.HKD","LU2476274720.SGD","LU0634319403.HKD","BK1161","LU0348825331.USD","IE00B543WZ88.USD","LU2488822045.USD","LU0561508036.HKD","LU0348827113.USD","BK1574","LU0417516738.SGD","LU2399975544.HKD","LU1961090484.USD","LU2476274308.USD","LU0417516571.SGD","IE00B5MMRT66.SGD","KURE","LU0348783233.USD","LU2778985437.USD","LU0348784397.USD","LU0348735423.USD","LU1720050803.USD","LU0348767384.USD","LU1794554557.SGD","09926","LU0417516902.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147226125","title":"AKESO Surges Over 9% in Session as Evonex Achieves Positive Phase III Results in Biliary Tract Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1147226125","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147226125?lang=en_us&edition=fundamental","pubTime":"2026-08-26 10:31","pubTimestamp":1787711462,"startTime":"0","endTime":"0","summary":"Shares of AKESO (09926) surged more than 9% during intraday trading before paring gains to trade 6.81% higher at HK$94.85, with turnover reaching HK$814 million. The sharp move followed the company's...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0417516902.SGD","LU0634319403.HKD","III","IE00B5MMRT66.SGD","LU0348766576.USD","IE00BPRC5H50.USD","KURE","LU2399975544.HKD","LU0561508036.HKD","LU1961090484.USD","LU1794554557.SGD","BK1161","LU2778985437.USD","BK1574","LU0348735423.USD","LU0417516738.SGD","LU0348783233.USD","LU0348825331.USD","LU2488822045.USD","LU0417516571.SGD","LU0348784397.USD","LU2476274308.USD","LU1720050803.USD","LU0348827113.USD","LU0540923850.HKD","IE00B543WZ88.USD","LU0348767384.USD","09926","LU2476274720.SGD","BK4134"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662766269","title":"Akeso's Ivonescimab Meets Primary Endpoint in Phase 3 Biliary Tract Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2662766269","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662766269?lang=en_us&edition=fundamental","pubTime":"2026-08-26 09:41","pubTimestamp":1787708502,"startTime":"0","endTime":"0","summary":"Akeso  said its PD-1/VEGF bispecific antibody ivonescimab plus chemotherapy met the primary endpoint in a Phase 3 trial for first-line treatment of advanced biliary tract cancer.The trial met its primary endpoint of overall survival, with key secondary endpoints of progression-free survival and objective response rate also met, according to a Wednesday filing with the Hong Kong bourse.The HARMONi-GI1 study enrolled 682 patients, marking ivonescimab's first positive Phase 3 result in gastrointestinal tumors, Akeso said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0417516571.SGD","LU0561508036.HKD","LU0348784397.USD","BK1574","LU2476274720.SGD","LU0348767384.USD","LU0417516738.SGD","LU1720050803.USD","LU0348766576.USD","LU0540923850.HKD","BK1161","LU2476274308.USD","IE00BPRC5H50.USD","KURE","LU2778985437.USD","LU0417516902.SGD","LU2488822045.USD","09926","IE00B543WZ88.USD","IE00B5MMRT66.SGD","LU1794554557.SGD","LU0348735423.USD","LU1961090484.USD","LU2399975544.HKD","LU0348825331.USD","LU0348827113.USD","LU0348783233.USD","LU0634319403.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153395418","title":"Movement Alert｜AKESO Rises 6.64% in Regular Trading, Phase III Trial for Ivonescimab in Biliary Tract Cancer Achieves Significant OS Benefit","url":"https://stock-news.laohu8.com/highlight/detail?id=1153395418","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153395418?lang=en_us&edition=fundamental","pubTime":"2026-08-26 09:33","pubTimestamp":1787708027,"startTime":"0","endTime":"0","summary":"On August 26, AKESO rose 6.64% in regular trading, trading at HK$93.7 per share, with turnover of HK$152 million.The move was driven by the company's announcement that its pivotal Phase III clinical...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"AKESO Surges on Ivonescimab Phase III OS Win in Biliary Cancer","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09926"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662766696","title":"Akeso Says Ivonescimab Plus Chemo Meets Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2662766696","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662766696?lang=en_us&edition=fundamental","pubTime":"2026-08-26 09:29","pubTimestamp":1787707747,"startTime":"0","endTime":"0","summary":"BRIEF-Akeso Says Ivonescimab Plus Chemo Meets Primary EndpointAug 26 (Reuters)-Akeso Inc9926.HK:IVONESCIMAB PLUS CHEMO MEETS PRIMARY ENDPOINT WITH SIGNIFICANT OS BENEFIT IN 1L BTCFurther company coverage:9926.HK","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44M0TW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1961090484.USD","LU0417516738.SGD","LU0561508036.HKD","BK1574","IE00BPRC5H50.USD","LU2488822045.USD","LU0348825331.USD","LU0348784397.USD","LU0348827113.USD","LU0417516571.SGD","LU0417516902.SGD","09926","LU2778985437.USD","LU2476274308.USD","LU1720050803.USD","LU0634319403.HKD","LU0348783233.USD","LU0348766576.USD","LU2399975544.HKD","LU0348735423.USD","LU1794554557.SGD","IE00B543WZ88.USD","BK1161","LU2476274720.SGD","LU0540923850.HKD","KURE","LU0348767384.USD","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115078027","title":"HK Stock Market Highlights: Haizhi Tech's H1 FY2026 Revenue Jumps 70.4% as Agent Business Takes Off","url":"https://stock-news.laohu8.com/highlight/detail?id=1115078027","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115078027?lang=en_us&edition=fundamental","pubTime":"2026-08-26 09:17","pubTimestamp":1787707028,"startTime":"0","endTime":"0","summary":"Key corporate developments this week: GenFleet Therapeutics-B (02595) has initiated a Phase II study evaluating GFH375, an oral KRAS G12D inhibitor, as a first-line treatment for non-small cell lung...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0417516738.SGD","BK1526","BK1586","LU2476274720.SGD","LU2399975544.HKD","IE00BPRC5H50.USD","LU2488822045.USD","LU1961090484.USD","IE00B5MMRT66.SGD","00354","LU0348766576.USD","KURE","LU0348783233.USD","LU0348827113.USD","LU0417516902.SGD","LU0348735423.USD","LU0348784397.USD","BK1155","LU0348825331.USD","BK1161","BK4588","LU0540923850.HKD","BK1518","BK1237","VXUS","LU2476274308.USD","LU2778985437.USD","LU0634319403.HKD","IE00B543WZ88.USD","BK4585","00660","BK1589","09926","LU0561508036.HKD","LU1794554557.SGD","LU1720050803.USD","02595","BK1574","LU0417516571.SGD","KCAI","LU0348767384.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197055899","title":"AKESO's Novel Dual Antibody Achieves Positive Phase III Results in Biliary Tract Cancer, Marking First Solid Tumor Expansion Beyond Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1197055899","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197055899?lang=en_us&edition=fundamental","pubTime":"2026-08-26 07:42","pubTimestamp":1787701336,"startTime":"0","endTime":"0","summary":"AKESO (09926) has announced that its independently developed, first-in-class bispecific antibody, 依达方® (ivonescimab, PD-1/VEGF), combined with chemotherapy, demonstrated a statistically significant...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348767384.USD","BK4134","LU2476274308.USD","LU0348827113.USD","LU0348735423.USD","LU1961090484.USD","IE00B5MMRT66.SGD","LU0348766576.USD","LU2476274720.SGD","III","BK1574","LU1720050803.USD","LU0348825331.USD","LU0348784397.USD","LU0417516571.SGD","LU0348783233.USD","LU0561508036.HKD","IE00B543WZ88.USD","LU0417516738.SGD","LU0417516902.SGD","KURE","09926","IE00BPRC5H50.USD","LU2488822045.USD","BK1161","LU2778985437.USD","LU0634319403.HKD","LU1794554557.SGD","LU0540923850.HKD","LU2399975544.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152757446","title":"Akeso: Ivonescimab Plus Chemotherapy Delivers Statistically Significant OS Improvement in Phase III Biliary Tract Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=1152757446","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152757446?lang=en_us&edition=fundamental","pubTime":"2026-08-26 07:07","pubTimestamp":1787699269,"startTime":"0","endTime":"0","summary":"Akeso (09926) announced that its PD-1/VEGF bispecific antibody ivonescimab, combined with chemotherapy, achieved the primary endpoint of overall survival (OS) in the Phase III HARMONi-GI1/AK112-309...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09926"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662685897","title":"Akeso - Ivonescimab Plus Chemo Meets Primary Endpoint with Significant Os Benefit in 1L BTC","url":"https://stock-news.laohu8.com/highlight/detail?id=2662685897","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662685897?lang=en_us&edition=fundamental","pubTime":"2026-08-26 07:01","pubTimestamp":1787698884,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nFWN44M0TW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0634319403.HKD","LU0348783233.USD","LU0417516902.SGD","LU2476274720.SGD","LU0540923850.HKD","LU1794554557.SGD","LU0348827113.USD","LU0417516738.SGD","IE00B543WZ88.USD","LU0417516571.SGD","LU0348825331.USD","BK1161","LU0561508036.HKD","LU2778985437.USD","LU2476274308.USD","LU0348784397.USD","IE00BPRC5H50.USD","KURE","LU0348735423.USD","BK1574","LU0348767384.USD","LU1961090484.USD","LU1720050803.USD","LU2488822045.USD","09926","IE00B5MMRT66.SGD","LU0348766576.USD","LU2399975544.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662752407","title":"Akeso - Harmoni-Gi1 First Phase Iii Study to Show Significant Os Benefit Versus Global Standard in Biliary Tract Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2662752407","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662752407?lang=en_us&edition=fundamental","pubTime":"2026-08-26 05:00","pubTimestamp":1787691600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nTUA5XV27P:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0348825331.USD","IE00BPRC5H50.USD","LU1794554557.SGD","LU0348784397.USD","09926","KURE","LU0348735423.USD","LU0417516571.SGD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU0348827113.USD","LU2488822045.USD","BK1161","LU0348767384.USD","LU2476274308.USD","LU2476274720.SGD","LU0348766576.USD","BK1574","LU0417516902.SGD","LU0561508036.HKD","LU2399975544.HKD","LU1720050803.USD","LU1961090484.USD","LU0348783233.USD","LU2778985437.USD","LU0540923850.HKD","LU0634319403.HKD","LU0417516738.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662524007","title":"Ivonescimab Plus Chemotherapy Demonstrates Significant Overall Survival Benefit Versus Durvalumab Plus Chemotherapy in First-Line Biliary Tract Cancer: Harmoni-Gi1 Meets Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2662524007","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662524007?lang=en_us&edition=fundamental","pubTime":"2026-08-26 05:00","pubTimestamp":1787691600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nTUA5XV27P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BPRC5H50.USD","LU0634319403.HKD","LU2778985437.USD","LU2476274308.USD","LU2399975544.HKD","LU2488822045.USD","BK1574","LU0348766576.USD","LU0417516571.SGD","LU1720050803.USD","LU0348783233.USD","LU0348735423.USD","LU1961090484.USD","LU0348825331.USD","LU0417516738.SGD","IE00B543WZ88.USD","LU0561508036.HKD","BK1161","09926","LU0348784397.USD","LU0417516902.SGD","LU0348767384.USD","KURE","LU2476274720.SGD","LU0540923850.HKD","LU0348827113.USD","LU1794554557.SGD","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662401752","title":"Akeso - Study Meets Key Secondary Endpoints of Progression-Free Survival and Objective Response Rate","url":"https://stock-news.laohu8.com/highlight/detail?id=2662401752","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662401752?lang=en_us&edition=fundamental","pubTime":"2026-08-26 05:00","pubTimestamp":1787691600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nTUA5XV27P:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KURE","LU2476274308.USD","LU0348825331.USD","LU0348783233.USD","LU0348827113.USD","LU0540923850.HKD","LU0561508036.HKD","BK1574","IE00BPRC5H50.USD","LU0417516571.SGD","LU0348766576.USD","LU1794554557.SGD","LU0417516902.SGD","LU2399975544.HKD","09926","LU2488822045.USD","IE00B5MMRT66.SGD","LU0348767384.USD","LU0634319403.HKD","LU0348735423.USD","LU0348784397.USD","LU1961090484.USD","IE00B543WZ88.USD","LU2778985437.USD","LU2476274720.SGD","BK1161","LU0417516738.SGD","LU1720050803.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123479551","title":"Movement Alert｜AKESO Rises 3.49% in Regular Trading, Interim Results Imminent and New ADC Pipeline Progress Boosts Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=1123479551","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123479551?lang=en_us&edition=fundamental","pubTime":"2026-08-24 09:36","pubTimestamp":1787535394,"startTime":"0","endTime":"0","summary":"On August 24, AKESO rose 3.49% in regular trading, trading at HK$92.55/share, with turnover of HK$88.28 million. The rebound follows a nearly 4% decline in the prior session.On the news front, the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"AKESO Surges as B7-H3 ADC Trial Nears Interim Results","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09926"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661528902","title":"Akeso Says China NMPA Clears Phase I Trial for B7-H3 ADC Ak157d1 in Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2661528902","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661528902?lang=en_us&edition=fundamental","pubTime":"2026-08-21 13:31","pubTimestamp":1787290275,"startTime":"0","endTime":"0","summary":"Akeso says China NMPA clears Phase I trial for B7-H3 ADC AK157D1 in solid tumorsAkeso secured China NMPA CDE clearance to start a Phase I trial of AK157D1, a B7-H3 antibody-drug conjugate, in advanced","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDLc1jnKH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2778985437.USD","LU0417516571.SGD","LU1720050803.USD","LU0348784397.USD","IE00BPRC5H50.USD","LU0348735423.USD","LU1794554557.SGD","LU2476274308.USD","LU0348767384.USD","LU2476274720.SGD","BK1161","LU0540923850.HKD","LU0348827113.USD","LU2399975544.HKD","BK1574","LU0348783233.USD","LU0634319403.HKD","IE00B543WZ88.USD","LU0417516902.SGD","09926","KURE","LU0561508036.HKD","LU0417516738.SGD","IE00B5MMRT66.SGD","LU0348825331.USD","LU1961090484.USD","LU0348766576.USD","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661252887","title":"Akeso's Ak157d1 (B7-H3 ADC) Cleared for Phase I Trial in Solid Tumors, Adding a Third Differentiated ADC to Its Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2661252887","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661252887?lang=en_us&edition=fundamental","pubTime":"2026-08-21 13:30","pubTimestamp":1787290258,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nTUA6ZY0XF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0417516738.SGD","LU2476274720.SGD","LU2399975544.HKD","IE00BPRC5H50.USD","LU2488822045.USD","LU1961090484.USD","IE00B5MMRT66.SGD","LU0348766576.USD","KURE","LU0348783233.USD","LU0348827113.USD","LU0417516902.SGD","LU0348735423.USD","LU0348784397.USD","LU0348825331.USD","BK1161","LU0540923850.HKD","LU2476274308.USD","LU2778985437.USD","LU0634319403.HKD","IE00B543WZ88.USD","09926","LU0561508036.HKD","LU1794554557.SGD","LU1720050803.USD","BK1574","LU0417516571.SGD","LU0348767384.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}